24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Exalenz
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:53
The breach that doesn’t have to happen - and what real cyber warfare looks like
13:42
"We are able to understand what drives cancer. This changes the entire course of the disease"
12:19
Why Disney is licensing AI instead of fighting it
11:53
Israeli healthtech faces a more selective funding market after the war
More stories
Buzz
Most popular
Daily
Weekly
1
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
UAE reportedly behind Elbit’s record $2.3 billion defense deal
4
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
5
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
More news
Exalenz
2 stories about Exalenz
Exalenz Bioscience Acquired for $49M
19.02.20
|
Golan Hazani
Israeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
19.02.20
|
Golan Hazani
Tel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source